Bringing the research sector together to advance the development of novel therapeutics for hearing loss and tinnitus.
Event details
- When: Thursday 13 November, registration opens from 8am, programme runs 9am-5pm, with networking from 5-7pm
- Where: 1 Wimpole Street, London
Be part of RNID Hearing Therapeutics Summit 2025
RNID Hearing Therapeutics Summit is open to anyone who has a professional interest in the development of novel therapeutics for hearing loss and tinnitus irrespective of sector background or career stage.
Join us for a full programme of engaging presentations, expert-led discussions and plentiful cross-sector networking opportunities.
Why attend?
- Expert speakers: Hear from key opinion leaders from across the hearing therapeutics development landscape.
- Research updates: Discover the latest findings from across the preclinic and clinical research spaces.
- Networking opportunities: Connect with researchers, industry experts, and potential collaborators to expand your network.
- Open engagement: Participate by raising questions in thought-provoking panel sessions that will open new lines of discussion.
Sessions overview
Lived experience: exploring the impact that potential new treatments to protect against hearing loss and tinnitus will have on people’s lives.
Preclinical and clinical lightning talks: collections of lightning talks to give focussed updates on specific pieces of work within the remit of early-stage preclinical or clinical stage research.
Focus on investment: using real-world examples from the hearing therapeutics field, this panel session will explore how early-stage companies or innovators identify, build and maintain productive relationship with potential funders.
Towards market access: it is important that healthcare regulators and payers can assess the value of novel therapeutics for hearing loss. In this session we will discuss recent initiatives aimed at addressing this need.
Beyond market authorisation: in this conversation we will explore the challenges of accessing newly approved medicines in novel therapeutic areas.
Looking to the future: to close the summit, we will be asking our expert panel members to reflect upon what they consider to be some of the biggest challenges and to discuss how we can accelerate progress towards a range of treatments for hearing loss and tinnitus.
- Morag Lewis (King’s College London)
- Erik de Vrieze (Radboud UMC)
- Adam Babbs (Medical Research Council)
- Hugo Peris (Spiral Therapeutics)
- Reimar Schlingensiepen (AudioCure Pharma)
- Laurent Desire (Sensorion)
- Rachel Haines (Rinri Therapeutics
- Jonas Dyhrfjeld-Johnsen (Acousia Therapeutics)
- Charles Large (Autifony)
- Colleen Le Prell (University of Texas at Dallas)
- Sarah Hughes (University of Birmingham)
- Elizabeth Klein-Edmonds (Calculus Capital)
With more speakers to be confirmed!
Register for an early bird discount
Our sponsors and supporters
An enormous thank you to our sponsors and supporters, without whom this event wouldn’t be possible.
Sponsorship opportunities
Want to showcase your brand and connect with the hearing therapeutics community? Become a sponsor for our summit. You’ll receive a range of benefits, including prominent visibility, engagement with key stakeholders, and exhibition opportunities.
Contact us to learn more about how you can support and benefit from sponsoring the summit.